SCHEMBL20304359

SCHEMBL20304359

NNCOc1cccc2cnccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 1/20 0.57
▸ LMNA P02545 3/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KDM4E B2RXH2 2/20 0.45
▸ MAPKAPK2 P49137 1/20 0.45
▸ NR3C1 P04150 2/20 0.45
▸ CACNA2D1 P54289 7/20 0.44
▸ IKBKE Q14164 1/20 0.43
▸ TBK1 Q9UHD2 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NSD2 O96028 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ PRKD3 O94806 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14251166 0.79 KCNA3 (0.61) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL94801 0.79 KCNA3 (0.61) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL11144866 0.79 KCNA3 (0.61) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL10576049 0.78 KCNA3 (0.69) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL4517253 0.77 KCNA3 (0.56) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL96699 0.76 KCNA3 (0.67) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL1545737 0.76 KCNA3 (0.71) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL10361892 0.76 KCNA3 (0.67) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL5449325 0.76 KCNA3 (0.67) KCNA3LMNACYP3A4CYP2D6CYP1A2
SCHEMBL4328934 0.76 KCNA3 (0.67) KCNA3LMNACYP3A4CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558969-A1 PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS Janssen Pharmaceutica NV (BE) 2019-10-30 — — EP disclosed
WO-2018119036-A1 PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS JANSSEN BIOTECH, INC. (US) 2018-06-28 — — WO disclosed
Send feedback